282 related articles for article (PubMed ID: 32272875)
21. Genome-Wide Analysis Identified a Number of Dysregulated Long Noncoding RNA (lncRNA) in Human Pancreatic Ductal Adenocarcinoma.
Hao S; Yao L; Huang J; He H; Yang F; Di Y; Jin C; Fu D
Technol Cancer Res Treat; 2018 Jan; 17():1533034617748429. PubMed ID: 29343207
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA TP53TG1 promotes pancreatic ductal adenocarcinoma development by acting as a molecular sponge of microRNA-96.
Zhang Y; Yang H; Du Y; Liu P; Zhang J; Li Y; Shen H; Xing L; Xue X; Chen J; Zhang X
Cancer Sci; 2019 Sep; 110(9):2760-2772. PubMed ID: 31325400
[TBL] [Abstract][Full Text] [Related]
23. The overexpression of long intergenic ncRNA00162 induced by RelA/p65 promotes growth of pancreatic ductal adenocarcinoma.
Lu Y; Wu M; Fu J; Sun Y; Furukawa K; Ling J; Qin X; Chiao PJ
Cell Prolif; 2020 May; 53(5):e12805. PubMed ID: 32364285
[TBL] [Abstract][Full Text] [Related]
24. The involvement of lncRNAs in the development and progression of pancreatic cancer.
Duguang L; Jin H; Xiaowei Q; Peng X; Xiaodong W; Zhennan L; Jianjun Q; Jie Y
Cancer Biol Ther; 2017 Dec; 18(12):927-936. PubMed ID: 29053398
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b.
Yang H; Liu P; Zhang J; Peng X; Lu Z; Yu S; Meng Y; Tong WM; Chen J
Oncogene; 2016 Jul; 35(28):3647-57. PubMed ID: 26549028
[TBL] [Abstract][Full Text] [Related]
26. LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR-539.
Nai Y; Pan C; Hu X; Ma Y
Cancer Med; 2020 Jan; 9(2):757-767. PubMed ID: 31789465
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of long noncoding RNA SNHG14 suppresses cell proliferation and invasion by regulating EZH2 in pancreatic ductal adenocarcinoma (PDAC).
Xie F; Huang Q; Wang C; Chen S; Liu C; Lin X; Lv X; Wang C
Cancer Biomark; 2020; 27(3):357-364. PubMed ID: 31929143
[TBL] [Abstract][Full Text] [Related]
28. High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma.
Ye Y; Chen J; Zhou Y; Fu Z; Zhou Q; Wang Y; Gao W; Zheng S; Zhao X; Chen T; Chen R
J Transl Med; 2015 Apr; 13():137. PubMed ID: 25925763
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA DLEU1 aggravates pancreatic ductal adenocarcinoma carcinogenesis via the miR-381/CXCR4 axis.
Gao S; Cai Y; Zhang H; Hu F; Hou L; Xu Q
J Cell Physiol; 2019 May; 234(5):6746-6757. PubMed ID: 30382579
[TBL] [Abstract][Full Text] [Related]
30. lncRNA
Li N; Yang G; Luo L; Ling L; Wang X; Shi L; Lan J; Jia X; Zhang Q; Long Z; Liu J; Hu W; He Z; Liu H; Liu W; Zheng G
Clin Cancer Res; 2020 Apr; 26(7):1736-1748. PubMed ID: 31831555
[TBL] [Abstract][Full Text] [Related]
31. Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma.
Song J; Xu Q; Zhang H; Yin X; Zhu C; Zhao K; Zhu J
J Cell Biochem; 2018 Jun; 119(6):4559-4569. PubMed ID: 29239017
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA CUDR promotes malignant phenotypes in pancreatic ductal adenocarcinoma via activating AKT and ERK signaling pathways.
Liang X; Qi M; Wu R; Liu A; Chen D; Tang L; Chen J; Hu X; Li W; Zhan L; Shao C
Int J Oncol; 2018 Dec; 53(6):2671-2682. PubMed ID: 30272271
[TBL] [Abstract][Full Text] [Related]
33. Role of long non-coding RNA H19 in therapy resistance of digestive system cancers.
Wang J; Ma X; Si H; Ma Z; Ma Y; Wang J; Cao B
Mol Med; 2021 Jan; 27(1):1. PubMed ID: 33402118
[TBL] [Abstract][Full Text] [Related]
34. Upregulated long non-coding RNA SPRY4-IT1 predicts dismal prognosis for pancreatic ductal adenocarcinoma and regulates cell proliferation and apoptosis.
Yao Y; Gao P; Chen L; Wang W; Zhang J; Li Q; Xu Y
Gene; 2018 Jun; 659():52-58. PubMed ID: 29551494
[TBL] [Abstract][Full Text] [Related]
35. Yin Yang-1 suppresses pancreatic ductal adenocarcinoma cell proliferation and tumor growth by regulating SOX2OT-SOX2 axis.
Zhang JJ; Zhu Y; Zhang XF; Liu DF; Wang Y; Yang C; Shi GD; Peng YP; Zhang K; Tian L; Miao Y; Jiang KR
Cancer Lett; 2017 Nov; 408():144-154. PubMed ID: 28867247
[TBL] [Abstract][Full Text] [Related]
36. Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma.
Li Z; Jiang P; Li J; Peng M; Zhao X; Zhang X; Chen K; Zhang Y; Liu H; Gan L; Bi H; Zhen P; Zhu J; Li X
Oncogene; 2018 Jul; 37(28):3822-3838. PubMed ID: 29643475
[TBL] [Abstract][Full Text] [Related]
37. Melittin-induced long non-coding RNA NONHSAT105177 inhibits proliferation and migration of pancreatic ductal adenocarcinoma.
Wang X; Li H; Lu X; Wen C; Huo Z; Shi M; Tang X; Chen H; Peng C; Fang Y; Deng X; Shen B
Cell Death Dis; 2018 Sep; 9(10):940. PubMed ID: 30237397
[TBL] [Abstract][Full Text] [Related]
38. Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma.
Wu Y; Wei J; Ming Y; Chen Z; Yu J; Mao R; Chen H; Zhou G; Fan Y
J Cell Biochem; 2018 Sep; 119(9):7696-7706. PubMed ID: 29923223
[TBL] [Abstract][Full Text] [Related]
39. Concepts to Target MYC in Pancreatic Cancer.
Wirth M; Mahboobi S; Krämer OH; Schneider G
Mol Cancer Ther; 2016 Aug; 15(8):1792-8. PubMed ID: 27406986
[TBL] [Abstract][Full Text] [Related]
40. Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues.
Liu JH; Chen G; Dang YW; Li CJ; Luo DZ
Asian Pac J Cancer Prev; 2014; 15(7):2971-7. PubMed ID: 24815433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
